August J. Troendle - Sep 20, 2023 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol
MEDP
Transactions as of
Sep 20, 2023
Transactions value $
-$31,833,495
Form type
4
Date filed
9/21/2023, 09:41 PM
Previous filing
Sep 20, 2023
Next filing
Nov 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Sale -$16.8M -65.7K -1.09% $255.48 5.98M Sep 20, 2023 By Medpace Investors, LLC F1, F2, F3
transaction MEDP Common Stock Sale -$15.1M -61.7K -1.03% $244.27 5.91M Sep 21, 2023 By Medpace Investors, LLC F1, F3, F4
holding MEDP Common Stock 807K Sep 20, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on May 1 2023.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $253.07 to $257.935. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3 The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $239.77 to $251.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.